Erythrodermic Mycosis Fungoides: The Algorithm of Diagnosis and Treatment

Autor: IN Chuprov, OYu Olisova, A A Sydikov, Ekaterina V. Grekova, SA Chernysh, VA Doronin, L. G Gorenkova

Publikováno v: Kliničeskaâ onkogematologiâ, Vol 11, Iss 4, Pp 295-302 (2018)

Erythrodermic mycosis fungoides (eMF) is an atypical severe form of mycosis fungoides resulting from persistent and treatment-resistant disease. eMF manifests as generalized skin bluish lesions, intense itching, secondary lymph-adenopathy, and signif

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb26715ae97609de2f43f53ae75bf286
http://bloodjournal.ru/wp-content/uploads/2018/09/3-1.pdf

[Laboratory and clinical characteristics of large granular lymphocyte leukemia]

Autor: Sa, Lugovskaia, Va, Doronin, Me, Pochtar, Ea, Nikitin, Andrey Sudarikov

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0e132e74ab81f2efe2867c6cd49a6861
https://pubmed.ncbi.nlm.nih.gov/12362632

[Complications in ultraviolet irradiation of the blood]

Autor: Alexey Marochkov, Va, Doronin, Nn, Kravtsov

Publikováno v: Europe PubMed Central

2380 sessions of ultraviolet blood irradiation have been analysed. A DRB-8 lamp was used as a source of irradiation. The complications observed were divided into 2 groups. Group 1 comprised complications associated with the technical performance of t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::dfe5f3cf774715d5f76145406f365040
https://pubmed.ncbi.nlm.nih.gov/2077972

Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML.

Autor: Adès L; INSERM U944, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Louis and University of Paris, Paris, France., Girshova L; Federal Almazov North-West Medical Research Centre, Saint-Petersburg, Russia., Doronin VA; City Clinical Hospital 40, Moscow, Russia., Díez-Campelo M; Institute for Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, Salamanca, Spain., Valcárcel D; Hematology Department, Vall Hebron Institute of Oncology (VHIO), Vall d'Hebron, University Hospital, Barcelona, Spain., Kambhampati S; Sarah Cannon at Research Medical Center, Kansas City, MO., Viniou NA; Hematology Unit, First, Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece., Woszczyk D; University of Opole, Provincial Hospital, Opole, Poland., De Paz Arias R; Hematology, Hospital Universitario La Paz-IDIPaz, Madrid, Spain., Symeonidis A; Hematology Division, Department of Internal Medicine, University Hospital Patras, Patras, Greece., Anagnostopoulos A; Hematology Department, General Hospital 'George Papanikolaou,' Thessaloniki, Greece., Munhoz EC; Hematology and Oncology Clinic, Erasto Gaertner Hospital, Curitiba, Brazil., Platzbecker U; Department of Hematology and Cellular Therapy, Leipzig University Hospital, Leipzig, Germany., Santini V; MDS (Myelodysplastic Syndrome) Unit, Hematology, Azienda Ospedaliero-Universitaria (AOU) Careggi, University of Florence, Florence, Italy., Fram RJ; Takeda Development Center Americas, Inc (TDCA), Lexington, MA; and., Yuan Y; Takeda Development Center Americas, Inc (TDCA), Lexington, MA; and., Friedlander S; Takeda Development Center Americas, Inc (TDCA), Lexington, MA; and., Faller DV; Takeda Development Center Americas, Inc (TDCA), Lexington, MA; and., Sekeres MA; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.

Publikováno v: Blood advances [Blood Adv] 2022 Sep 13; Vol. 6 (17), pp. 5132-5145.

[Current aspects of the pathogenesis and diagnosis of chronic lymphocytic leukemia (review of literature)].

Autor: Doronin VA

Publikováno v: Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 2003 Apr (4), pp. 24, 33-40.